These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2184144)

  • 21. [Protracted blood sugar increase in type 1 diabetics after brief but exhausting muscular exercise].
    Böhmer K; Renner R; Hepp KD; Landgraf R
    Dtsch Med Wochenschr; 1989 May; 114(21):821-4. PubMed ID: 2721386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of aging on growth hormone, ACTH and cortisol response to insulin-induced hypoglycemia in type I diabetes.
    Muggeo M; Moghetti P; Querena M; Girotto S; Bonora E; Crepaldi G
    Acta Diabetol Lat; 1985; 22(2):159-68. PubMed ID: 3000117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of administration of human growth hormone on the plasma growth hormone, cortisol, glucose, and free fatty acid response to insulin: evidence for growth hormone autoregulation in man.
    Abrams RL; Grumbach MM; Kaplan SL
    J Clin Invest; 1971 Apr; 50(4):940-50. PubMed ID: 4926262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defective epinephrine and growth hormone responses in type I diabetes are stimulus specific.
    Hirsch BR; Shamoon H
    Diabetes; 1987 Jan; 36(1):20-6. PubMed ID: 3792663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies of growth hormone secretion in juvenile diabetes.
    Locard E; David L; Ruitton A; de Chabanolle F; François R
    Horm Res; 1979; 11(1):29-40. PubMed ID: 478438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultradian growth hormone rhythm in the rat: effects of feeding, hyperglycemia, and insulin-induced hypoglycemia.
    Tannenbaum GS; Martin JB; Colle E
    Endocrinology; 1976 Sep; 99(3):720-7. PubMed ID: 954665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal growth hormone levels in insulin-dependent diabetic patients under continuous subcutaneous insulin infusion and intensified conventional treatment.
    Arias P; Kerner W; de la Fuente A; Pfeiffer EF
    Acta Endocrinol (Copenh); 1984 Oct; 107(2):250-5. PubMed ID: 6388208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Importance of growth hormone for blood glucose regulation following insulin-induced nocturnal hypoglycemia in insulin-dependent diabetes mellitus.
    Kollind M; Adamson U; Lins PE; Curstedt T
    Acta Med Scand; 1988; 223(2):159-64. PubMed ID: 2894751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of midday moderate-intensity exercise on postexercise hypoglycemia risk in individuals with type 1 diabetes.
    Davey RJ; Howe W; Paramalingam N; Ferreira LD; Davis EA; Fournier PA; Jones TW
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2908-14. PubMed ID: 23780373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholinergic muscarinic receptor blockade suppresses arginine- and exercise-induced growth hormone secretion in type I diabetic subjects.
    Arends J; Wagner ML; Willms BL
    J Clin Endocrinol Metab; 1988 Feb; 66(2):389-94. PubMed ID: 3339112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of acute hypercalcaemia on arginine induced growth hormone release in diabetic man.
    Kaplan PW; Jung RT
    Horm Metab Res; 1984 Dec; 16 Suppl 1():123-6. PubMed ID: 6532933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clonidine and GH secretion in insulin dependent diabetes (IDD).
    Speroni G; Ceda GP; Capretti L; Valenti G
    Horm Metab Res; 1983 Jan; 15(1):46-7. PubMed ID: 6299919
    [No Abstract]   [Full Text] [Related]  

  • 33. Abnormal arginine-vasopressin responses to metoclopramide and insulin-induced hypoglycemia in type I diabetes mellitus.
    Coiro V; Capretti L; Speroni G; Volpi R; Caiazza A; Rossi G; Bianconi L; Chiodera P
    Horm Res; 1990; 33(6):227-32. PubMed ID: 2289781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nocturnal growth hormone surges in type 1 diabetes mellitus are both sleep- and glycemia-dependent: assessment under continuous sleep monitoring.
    Serrano Ríos M; Navascués I; Ordóñez A; Sabán J; Núnez A; Sánchez M; García Austt E
    Diabetes Res Clin Pract; 1990; 10(1):1-8. PubMed ID: 2249602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exercise and glycemic imbalances: a situation-specific estimate of glucose supplement.
    Francescato MP; Geat M; Accardo A; Blokar M; Cattin L; Noacco C
    Med Sci Sports Exerc; 2011 Jan; 43(1):2-11. PubMed ID: 20473219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blunted Counterregulatory hormone responses to hypoglycemia in young children and adolescents with well-controlled type 1 diabetes: response to the Diabetes Research in Children Network (DirecNet) Study Group.
    Graveling AJ; Warren RE; Frier BM
    Diabetes Care; 2010 May; 33(5):e67; author reply e68. PubMed ID: 20427676
    [No Abstract]   [Full Text] [Related]  

  • 37. Dopaminergic stimulation and inhibition of growth hormone secretion in normal man: studies of the pharmacologic specificity.
    Bansal SA; Lee LA; Woolf PD
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1273-7. PubMed ID: 7028777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Humoral antibacterial immunity in first degree relatives of insulin-dependent diabetics.
    Schernthaner G; Ludwig H; Mayr WR; Eibl M
    Diabete Metab; 1978 Sep; 4(3):163-7. PubMed ID: 710677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired adrenergic response to prolonged exercise in type I diabetes.
    Schneider SH; Vitug A; Ananthakrishnan R; Khachadurian AK
    Metabolism; 1991 Nov; 40(11):1219-25. PubMed ID: 1943751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth hormone response to growth hormone releasing factor in diabetic men.
    Kopelman PG; Mason AC; Noonan K; Monson JP
    Clin Endocrinol (Oxf); 1988 Jan; 28(1):33-8. PubMed ID: 3139333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.